Abstract
This project aims to develop and optimize a mouse skin organoid system, creating an alternative to animal use in experimentation, in line with the principles of the 3Rs (reduction, refinement, and replacement). The use of organoids will allow multiple experiments to be conducted from a single animal, significantly reducing the use of mice. The goal is to create a skin organoid model that more accurately simulates the interaction of skin cells with cutaneous pathogens and drugs, providing an innovative platform for research that traditionally relies on whole animal models.The system will be developed from dermal samples of mice, and one advantage of this model is the ability to generate multiple organoids from a single animal, reducing the need for multiple mice. Furthermore, the system will enable the use of genetically modified mice, allowing the study of cells and tissues with specific characteristics, such as resistance to pathogens or drug response, without interference from the adaptive immune system or cell migration, since the organoids lack lymph nodes and there is no possibility of cell migration from the bone marrow or other organs.This model will be validated using pathogens such as Leishmania spp. and Mycobacterium leprae, as well as endogenous retroviruses from the skin. The model will allow the investigation of interactions between skin cells and these pathogens, as well as the effects of different pharmacological treatments, providing valuable data on mechanisms of pathogenesis and cellular response. Additionally, the system will be useful for evaluating new therapies for cutaneous infectious diseases.In addition to contributing to the reduction of animal use, the organoid system will advance the study of immunology, particularly in the local immune response of the skin. The absence of lymph nodes in the organoids will allow for a precise analysis of the immune response without interference from the adaptive immune system, enabling the study of the skin as a primary immune barrier and its interaction with pathogens. Studying skin cells resistant to infections will provide new insights into the mechanisms of resistance and tolerance to pathogens.The expected impact of the project goes beyond the reduction of animal use. It also aims to generate new knowledge about cutaneous infectious diseases, mechanisms of resistance to pathogens, and drug effects. The organoid system can be applied to other areas of research, such as autoimmune diseases and cancer, expanding its applicability. The innovation and data generated on cells resistant to pathogens will contribute to the advancement of science at both national and international levels.The developed system will serve as a reference model for the various research projects supporting this proposal, as well as for other ongoing research projects in the state of São Paulo, encouraging the adoption of methodologies in line with the 3Rs principles. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |